Abstract | BACKGROUND: OBJECTIVE: The current study aimed to evaluate the relationship between serum levels of MMP-11 and prognosis in colon cancer patients. METHODS: Serum levels of MMP-11 were determined in 92 colon cancer patients and 92 healthy individuals using an enzyme-linked immunosorbent assay (ELISA). Associations between serum MMP-11 levels and clinicopathological characteristics of the patients and their outcomes were investigated. Survival analyses were performed to measure the 5-year overall survival (OS) and disease-free survival (DFS). RESULTS: Serum MMP-11 levels were substantially higher in colon cancer patients than in healthy controls. Moreover, serum MMP-11 levels were significantly higher in patients with advanced T status, lymph node metastasis, distant metastasis, and a higher TNM stage. Elevated serum levels of MMP-11 were identified as an independent prognostic factor for 5-year mortality and adverse events associated with colon cancer. Multivariate Cox regression analysis identified the serum MMP-11 level as an independent predictor of OS and DFS. CONCLUSION: Our study established that high serum levels of MMP-11 are associated with poor clinical outcome and may serve as a prognostic biomarker in colon cancer patients.
|
Authors | Li Pang, Da-Wei Wang, Nan Zhang, Da-Hai Xu, Xiang-Wei Meng |
Journal | Cancer biomarkers : section A of Disease markers
(Cancer Biomark)
Vol. 16
Issue 4
Pg. 599-607
(Mar 11 2016)
ISSN: 1875-8592 [Electronic] Netherlands |
PMID | 27002762
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- MMP11 protein, human
- Matrix Metalloproteinase 11
|
Topics |
- Adult
- Aged
- Biomarkers, Tumor
- Case-Control Studies
- Colonic Neoplasms
(blood, diagnosis, drug therapy, mortality)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Male
- Matrix Metalloproteinase 11
(blood)
- Middle Aged
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Staging
- Prognosis
- ROC Curve
|